External Reference Pricing in Pharmaceutical Industry - Francis Marete - Books - Grin Publishing - 9783656733591 - September 16, 2014
In case cover and title do not match, the title is correct

External Reference Pricing in Pharmaceutical Industry

Price
HK$ 157
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jun 9 - 15
Add to your iMusic wish list

Seminar paper from the year 2012 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: B, Stanford University, language: English, abstract: In the marketing practice, marketers largely focus on four key elements that include the product itself, the price of the product, the place, or the location where the product or service is made available for the customers and the promotional activities that are geared towards creating awareness of the product and informing the target audience about its unique attributes. In all of the four marketing elements, it is only price, which is revenue generating and it plays a crucial role in ensuring that a particular product or service sales in large volumes thereby making a company more profitable. In the determination of price, various factors come into play and they include cost of producing the product or delivering the service, the economic condition of the target market, competition level in the market, the brand name of the product/ service, and the quality of the product/ service (Baines et al. 2013). Under competition, marketers tend to consider the price of other competing product/ service whilst setting the new price and this strategy is called external reference pricing. According to Trivedi (2002), the idea behind this pricing strategy is that the price should not be too high or low to the competing products/ services. In the pharmaceutical industry, external reference pricing, is commonly applied in order for the government to tame the prices of pharmaceutical products that are protected by intellectual property rights and even enable the pharmaceutical companies to benefit from a created monopoly arising from the patented drugs. This present study seeks to investigate the flaws of external reference pricing strategy in the pharmaceutical industry from the point of view of PainCeptor Pharma in Canada, and it will seek to provide a recommendation to the C


12 pages

Media Books     Paperback Book   (Book with soft cover and glued back)
Released September 16, 2014
ISBN13 9783656733591
Publishers Grin Publishing
Pages 12
Dimensions 178 × 254 × 1 mm   ·   34 g
Language German  

More by Francis Marete

Show all

Mere med samme udgiver